iShares Biotechnology ETF
IBB
- $174.23
- 0.15
- 0.08%
iShares Biotechnology ETF IBB Strategy
The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Future Focus: 4 ETFs every investor should know
Build smarter portfolios by separating ETFs into intuitive categories.
etfs
A shortcut to finding the right ETF
A few guiding questions to make sure you’re on the right track.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,139.90 | 34.50 | -0.38% |
| CAC 40 | 8,342.99 | 19.71 | 0.24% |
| DAX 40 | 24,981.39 | 33.48 | -0.13% |
| Dow JONES (US) | 50,469.83 | 333.96 | 0.67% |
| FTSE 100 | 10,344.59 | 41.64 | -0.40% |
| HKSE | 27,183.15 | 155.99 | 0.58% |
| NASDAQ | 23,190.71 | 47.96 | -0.21% |
| Nikkei 225 | 57,650.54 | 1,286.60 | 2.28% |
| NZX 50 Index | 13,513.68 | 67.31 | 0.50% |
| S&P 500 | 6,969.50 | 4.68 | 0.07% |
| S&P/ASX 200 | 8,867.40 | 44.20 | -0.50% |
| SSE Composite Index | 4,128.37 | 5.28 | 0.13% |